-
1
-
-
0033667435
-
Diagnostic testing for coagulopathies in patients with ischemic stroke
-
Bushnell C.D., and Goldstein L.B. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31 (2000) 3067-3078
-
(2000)
Stroke
, vol.31
, pp. 3067-3078
-
-
Bushnell, C.D.1
Goldstein, L.B.2
-
2
-
-
0028939318
-
Characterization of the molecular defect in factor VR506Q
-
Kalafatis M., Bertina R.M., Rand M.D., and Mann K.G. Characterization of the molecular defect in factor VR506Q. J Biol Chem 270 (1995) 4053-4057
-
(1995)
J Biol Chem
, vol.270
, pp. 4053-4057
-
-
Kalafatis, M.1
Bertina, R.M.2
Rand, M.D.3
Mann, K.G.4
-
3
-
-
0029133654
-
Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factorVaR506Q by activated protein C
-
Nicolaes G.A., Tans G., Thomassen M.C., Hemker H.C., Pabinger I., Varadi K., Schwarz H.P., et al. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factorVaR506Q by activated protein C. J Biol Chem 270 (1995) 21158-21166
-
(1995)
J Biol Chem
, vol.270
, pp. 21158-21166
-
-
Nicolaes, G.A.1
Tans, G.2
Thomassen, M.C.3
Hemker, H.C.4
Pabinger, I.5
Varadi, K.6
Schwarz, H.P.7
-
4
-
-
0029792536
-
Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation
-
Varadi K., Rosing J., Tans G., Pabinger I., Keil B., and Schwarz H.P. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation. Thromb Haemost 76 (1996) 208-214
-
(1996)
Thromb Haemost
, vol.76
, pp. 208-214
-
-
Varadi, K.1
Rosing, J.2
Tans, G.3
Pabinger, I.4
Keil, B.5
Schwarz, H.P.6
-
5
-
-
0033561431
-
Cleavage of Factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V
-
Thorelli E., Kaufman R.J., and Dahlback B. Cleavage of Factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood 93 (1999) 2552-2558
-
(1999)
Blood
, vol.93
, pp. 2552-2558
-
-
Thorelli, E.1
Kaufman, R.J.2
Dahlback, B.3
-
6
-
-
0028931717
-
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
-
Rosendaal F.R., Koster T., Vandenbroucke J.P., and Reitsma P.H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85 (1995) 1504-1508
-
(1995)
Blood
, vol.85
, pp. 1504-1508
-
-
Rosendaal, F.R.1
Koster, T.2
Vandenbroucke, J.P.3
Reitsma, P.H.4
-
7
-
-
0032520041
-
Factor V Cambridge. A new mutation (Arg306 to Thr) associated with resistance to activated protein C
-
Williamson D., Brown K., Luddington R., and Baglin C. Factor V Cambridge. A new mutation (Arg306 to Thr) associated with resistance to activated protein C. Blood 91 (1998) 1140
-
(1998)
Blood
, vol.91
, pp. 1140
-
-
Williamson, D.1
Brown, K.2
Luddington, R.3
Baglin, C.4
-
8
-
-
0032520034
-
A novel mutation of Arg306 of factor V gene in Hong Kong Chinese
-
Chan W.P., Lee C.K., Kwong Y.L., Lam C.K., and Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91 (1998) 1135
-
(1998)
Blood
, vol.91
, pp. 1135
-
-
Chan, W.P.1
Lee, C.K.2
Kwong, Y.L.3
Lam, C.K.4
Liang, R.5
-
9
-
-
0030860494
-
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype
-
Bernardi F., Faioni E.M., Castoldi E., Lunghi B., Castaman G., Sacchi E., Mannucci P.M., et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 90 (1997) 1552-1557
-
(1997)
Blood
, vol.90
, pp. 1552-1557
-
-
Bernardi, F.1
Faioni, E.M.2
Castoldi, E.3
Lunghi, B.4
Castaman, G.5
Sacchi, E.6
Mannucci, P.M.7
-
10
-
-
9044228783
-
Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma
-
Lunghi B., Iacoviello L., Gemmati D., Dilasio M.G., Castoldi E., Pinotti M., Castaman G., et al. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 75 (1996) 45-48
-
(1996)
Thromb Haemost
, vol.75
, pp. 45-48
-
-
Lunghi, B.1
Iacoviello, L.2
Gemmati, D.3
Dilasio, M.G.4
Castoldi, E.5
Pinotti, M.6
Castaman, G.7
-
11
-
-
0031059758
-
Prevalence of factor V Leiden mutation in non-European populations
-
Pepe G., Rickards O., Vanegas O.C., Brunelli T., Gori A.M., Giusti B., Attanasio M., et al. Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost. 77 (1997) 329-331
-
(1997)
Thromb Haemost.
, vol.77
, pp. 329-331
-
-
Pepe, G.1
Rickards, O.2
Vanegas, O.C.3
Brunelli, T.4
Gori, A.M.5
Giusti, B.6
Attanasio, M.7
-
13
-
-
0024365425
-
Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits
-
Noe D.A., Murphy P.A., Bell W.R., and Siegel J.N. Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am J Physiol. 257 (1989) R49-56
-
(1989)
Am J Physiol.
, vol.257
-
-
Noe, D.A.1
Murphy, P.A.2
Bell, W.R.3
Siegel, J.N.4
-
14
-
-
0036908576
-
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)
-
Tsai A.W., Cushman M., Rosamond W.D., Heckbert S.R., Tracy R.P., Aleksic N., and Folsom A.R. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 113 (2002) 636-642
-
(2002)
Am J Med.
, vol.113
, pp. 636-642
-
-
Tsai, A.W.1
Cushman, M.2
Rosamond, W.D.3
Heckbert, S.R.4
Tracy, R.P.5
Aleksic, N.6
Folsom, A.R.7
-
15
-
-
18644369163
-
Thrombophilia, clinical factors, and recurrent venous thrombotic events
-
Christiansen S.C., Cannegieter S.C., Koster T., Vandenbroucke J.P., and Rosendaal F.R. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 293 (May 18 2005) 2352-2361
-
(2005)
JAMA.
, vol.293
, pp. 2352-2361
-
-
Christiansen, S.C.1
Cannegieter, S.C.2
Koster, T.3
Vandenbroucke, J.P.4
Rosendaal, F.R.5
-
16
-
-
42749088081
-
Factor V Leiden: Is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?
-
Biswas A., Bajaj J., Ranjan R., Meena A., Akhter M.S., Yadav B.K., Sharma V., et al. Factor V Leiden: Is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?. Clin Chim Acta 392 (2008) 21-24
-
(2008)
Clin Chim Acta
, vol.392
, pp. 21-24
-
-
Biswas, A.1
Bajaj, J.2
Ranjan, R.3
Meena, A.4
Akhter, M.S.5
Yadav, B.K.6
Sharma, V.7
-
17
-
-
0035830874
-
Homocysteine inhibits inactivation of factor Va by activated protein C
-
Undas A., Williams E.B., Butenas S., Orfeo T., and Mann K.G. Homocysteine inhibits inactivation of factor Va by activated protein C. J Biol Chem 276 (2001) 4389-4397
-
(2001)
J Biol Chem
, vol.276
, pp. 4389-4397
-
-
Undas, A.1
Williams, E.B.2
Butenas, S.3
Orfeo, T.4
Mann, K.G.5
-
18
-
-
85047687532
-
Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden"
-
Graf L.L., Welsh C.H., Qamar Z., and Marlar R.A. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden". Am J Clin Pathol 119 (2003) 52-60
-
(2003)
Am J Clin Pathol
, vol.119
, pp. 52-60
-
-
Graf, L.L.1
Welsh, C.H.2
Qamar, Z.3
Marlar, R.A.4
-
19
-
-
0037946750
-
"Evaluation of the factor V HR2 haplotype as a risk factor for ischemic cerebrovascular disease"
-
Lecumberri R., Ceberio I., Montes R., López M.L., Alberca I., Rocha E., et al. "Evaluation of the factor V HR2 haplotype as a risk factor for ischemic cerebrovascular disease". Haematologica 88 (2003) 236-237
-
(2003)
Haematologica
, vol.88
, pp. 236-237
-
-
Lecumberri, R.1
Ceberio, I.2
Montes, R.3
López, M.L.4
Alberca, I.5
Rocha, E.6
-
20
-
-
13244260855
-
Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke
-
Duran R., Biner B., Demir M., Celtik C., and Karasalihoǧlu S. Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost 11 (2005) 83-88
-
(2005)
Clin Appl Thromb Hemost
, vol.11
, pp. 83-88
-
-
Duran, R.1
Biner, B.2
Demir, M.3
Celtik, C.4
Karasalihoǧlu, S.5
-
21
-
-
0033578475
-
Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators
-
Folsom A.R., Rosamond W.D., Shahar E., Cooper L.S., Aleksic N., Nieto F.J., Rasmussen M.L., et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100 (1999) 736-742
-
(1999)
Circulation
, vol.100
, pp. 736-742
-
-
Folsom, A.R.1
Rosamond, W.D.2
Shahar, E.3
Cooper, L.S.4
Aleksic, N.5
Nieto, F.J.6
Rasmussen, M.L.7
-
22
-
-
0033965871
-
Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response
-
O'Donnell J., Mumford A.D., Manning R.A., and Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 83 (2000) 10-13
-
(2000)
Thromb Haemost
, vol.83
, pp. 10-13
-
-
O'Donnell, J.1
Mumford, A.D.2
Manning, R.A.3
Laffan, M.4
-
23
-
-
0028793802
-
Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity
-
Henkens C.M., Bom V.J., and van der Meer J. Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity. Thromb Haemost 74 (1995) 1198-1199
-
(1995)
Thromb Haemost
, vol.74
, pp. 1198-1199
-
-
Henkens, C.M.1
Bom, V.J.2
van der Meer, J.3
|